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Abstract

Author Manuscript

The DNA Topoisomerase I enzyme of Mycobacterium tuberculosis (MtTOP1) is essential for the
viability of the organism and survival in a murine model. This topoisomerase is being pursued as a
novel target for the discovery of new therapeutic agents for the treatment of drug resistant
tuberculosis (TB). In this study, we succeeded in obtaining a structure of MtTOP1 by first
predicting that the C-terminal region of MtTOP1 contains four repeated domains that do not
involve the Zn-binding tetra-cysteine motifs seen in the C-terminal domains of E. coli
topoisomerase I. A construct (a.a. A2-T704), MtTOP1-704t, that includes the N-terminal domains
(D1-D4) and the first predicted C-terminal domain (D5) of MtTOP1 was expressed and found to
retain DNA cleavage-religation activity and catalyze ssDNA catenation. MtTOP1-704t was
crystallized, and a structure of 2.52 Å resolution limit was obtained. The structure of the MtTOP1
N-terminal domains has features that have not been observed in the other previously available
bacterial topoisomerase I crystal structures. The first C-terminal domain D5 forms a novel protein
fold of a four-stranded antiparallel β-sheet stabilized by a crossing-over α-helix. Since there is
only one type IA topoisomerase present in Mycobacteriaceae and related Actinobacteria, this
subfamily of type IA topoisomerase may be required for multiple functions in DNA replication,
transcription, recombination, and repair. The unique structural features observed for MtTOP1 may
allow these topoisomerase I enzymes to carry out physiological functions associated with
topoisomerase III enzyme in other bacteria.
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Introduction
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Topoisomerases are needed in all organisms to maintain the optimal level of DNA
supercoiling for physiological functions, and to resolve topological barriers encountered
during processes of replication, transcription, recombination, and repair.1, 2 In most
organisms, multiple topoisomerases are present, and each cellular topoisomerase has
specific roles associated with these physiological processes.3 The genome of the pathogen
Mycobacterium tuberculosis encodes only one type I topoisomerase that catalyzes
topological transitions by cutting and rejoining a single-strand of DNA and one type II
topoisomerase that carries out catalysis by cutting and rejoining a double-strand of DNA.
The type II topoisomerase (DNA gyrase) of M. tuberculosis is the target of moxifloxacin, a
fluoroquinolone antibacterial agent being utilized in a new tuberculosis (TB) drug
combination regimen and found to be beneficial for reducing TB treatment duration.4 The
only type I topoisomerase in M. tuberculosis (MtTOP1, Rv3646c) is a type IA
topoisomerase that has been found to be essential for growth, and its depletion was shown to
decrease survival following treatment with novobiocin and isoniazid.5 Each year, around 9
million people worldwide develop TB caused by Mycobacterium tuberculosis, accounting
for 1.3 million deaths. MtTOP1 has been actively investigated as a target for novel TB
drugs6–8 that are very much needed for the treatment of drug-resistant TB. The structure of
MtTOP1 will be essential for structure-based rational drug discovery efforts.

Author Manuscript

Our early trials to obtain diffraction quality crystals of the full length MtTOP1 protein were
unsuccessful. Constructs of the MtTOP1 N-terminal region corresponding to the N-terminal
domains D1-D4 found in E. coli topoisomerase I (EcTOP1) crystal structures did not
express well as soluble proteins. In a recently determined structure of full length EcTOP1 in
complex with ssDNA9 (PDB ID: 4RUL), the C-terminal region of EcTOP1 comprises three
4-Cys zinc ribbon domains and two zinc ribbon-like domains, and a modular ssDNAbinding mode was observed. This suggests that the C-terminal region of MtTOP1 may also
contain multiple domains with repeated and conserved sequence motifs even though the
sequences of EcTOP1 and MtTOP1 C-terminal regions are very different with essentially no
homologies. We analyzed the structural aspects of the C-terminal region of MtTOP1. The
recognition of individual domains in this region helped us redesign constructs for functional
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studies and enabled us to obtain diffraction quality crystals for structural characterization of
MtTOP1. We report here the crystal structure of MtTOP1-704t with the N-terminal domains
D1-D4 and C-terminal domain D5 (a.a. A2-T704) and its functional characterizations.

Results
Analysis of C-terminal domains of MtTOP1

Author Manuscript

MtTOP1 does not have easily recognizable sequence motifs (such as the repeated 4-Cys Znbinding motifs present in EcTOP1) that can help divide the MtTOP1 C-terminal region into
domains. Nevertheless, MtTOP1 does bear four GxxGPY sequence motifs10 in its Cterminal region. Based on the locations of the four GxxGPY repeats, we divided the region
into four repeat domains (Fig. 1). A secondary structure prediction indicated that each
domain comprises three or four β-strands and one C-terminal α-helix.11 The predicted
folding of the MtTOP1 C-terminal domains is different from the zinc ribbon domains or zinc
ribbon-like domains found in EcTOP1 and Thermotoga maritima topoisomerase I.12 After
the fourth or last C-terminal domain there is an additional long highly positively charged tail
(~ 26 amino acids) in MtTOP1. Besides the basic C-terminal tail, there are two more
stretches of basic amino acids.13 Based on the prediction, one is a part of the insertion on the
loop between the β3 and β4 strands of D6, and the other is a part of the linker between the
D7 and D8 domains (Fig. 1). Deletions of the stretches of basic amino acids in the Cterminal region of MtTOP1 have been shown to affect DNA binding and DNA strand
passage.13 The deletions would unlikely make an impact on the folding of the individual Cterminal domains but may affect the relative orientations of the C-terminal domains and the
inter-domain flexibility.
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MtTOP1-704t is one of the constructs that have been made based on the C-terminal domain
prediction above. It spans from amino acid A2 to T704 and includes the N-terminal domains
and the first predicted C-terminal domain D5 (Fig. 1 and Graphical Abstract). The functional
and structural characterization of MtTOP1-704t is the focus of this study.
Biochemical activities of MtTOP1-704t
MtTOP1-704t can be expressed readily as a soluble recombinant protein in E. coli host
strain T7 Express Crystal. The protein was purified to >99% homogeneity and assayed for
relaxation of negatively supercoiled plasmid DNA. The results in Fig. 2 showed that while
relaxation activity can be detected with 6.2 ng (60 fmole) of the full length MtTOP1,
relaxation activity was not observed with 100 ng (1.3 pmole) of MtTOP1-704t.

Author Manuscript

Although relaxation activity could not be detected for MtTOP1-704t, the protein was found
to have DNA cleavage activity similar to that of full length MtTOP1 (Fig. 3A). The same
preferred cleavage site with a cytosine base that is four nucleotides upstream of the cleavage
site was recognized for formation of the cleavage product.14 Intramolecular religation was
promoted by adding Mg(II) to shift the cleavage-religation equilibrium toward religation
along with 1 M NaCl to dissociate the non-covalent enzyme-DNA complex. The results in
Fig. 3B showed that MtTOP1-704t is efficient in DNA religation, so the C-terminal
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sequences not found in MtTOP1-704t do not affect the cleavage and rejoining of ssDNA by
MtTOP1.

Author Manuscript

There are two types of IA topoisomerases in most species of bacteria that have been studied.
E. coli topoisomerase III (EcTOP3) is much more efficient than EcTOP1 in DNA
catenation/decatenation, while EcTOP1 can remove negative supercoils much more
rapidly.15 Since M. tuberculosis only has one type of IA topoisomerase enzyme, MtTOP1 is
likely to be required for the resolution of single-stranded DNA recombination and
replication intermediates. The catenation activity of Mycobacterium smegmatis
topoisomerase I has been demonstrated previously with M13 single-stranded DNA.16 Since
MtTOP1-704t was found to have robust DNA cleavage-religation capabilities, the truncated
enzyme was assayed for catenation of single-stranded M13mp18 DNA circles to determine
if it can catalyze passage of a single-stranded DNA through the break created by enzyme
cleavage on another single-strand. The results (Fig. 4) showed that MtTOP1-T704 has
comparable catenation activity to that of full length MtTOP1.
Overall structure of MtTOP1-704t

Author Manuscript

The crystal structure of MtTOP1-704t was determined with molecular replacement17 and
alternative cycles of model building and refinement (Table 1). In the asymmetric unit, there
is one MtTOP1-704t as shown in Fig. 5. The 15 N-terminal residues (A2 to S16) are not
visible in the electron density maps of the structure. This indicates the flexible nature of the
N-terminal leading peptide, and the flexibility is consistent with its glycine-rich (five Gly
residues) composition. Interestingly, the first 15 residues (A2 to S16) of the peptide are
“extra” compared to EcTOP1, Fig. 6. Additionally, the leading peptide is positively charged
(including one Arg and two Lys residues, Supplementary Fig. 1). The functionality of this
leading peptide is currently unknown.
The model of the crystal structure of MtTOP1-704t starts from G17, which corresponds to
the starting residue G2 of the EcTOP1 structure (Fig. 6). There is no indication for a stable
quaternary assembly based on a PISA (Protein, Interface, Structures, and Assemblies)
analysis,18 which is consistent with the observation that MtTOP1 is a monomer in solution.
The four N-terminal domains (D1-D4, G17-A638) have a similar toroid assembly as
EcTOP1 (G2-N590) while the first C-terminal domain D5 shows sequential and structural
novelties among known protein folds as discussed later.

Author Manuscript

To evaluate the similarity of the N-terminal assembly of MtTOP1 to that of EcTOP1, the Nterminal domains of these two molecules were aligned,19 resulting in a root mean square
deviation (rmsd) of 1.92 Å and sequence identity of 44.9% (Fig. 7A). Pair-wise alignments
of individual domains resulted in rmsd values of 1.01 Å, 1.46 Å, 1.35 Å, and 1.39 Å for D1,
D2, D3, and D4, respectively. Their sequence identities are 56.0%, 26.9%, 49.6%, and
49.2%, respectively. Apparently, D1 is the most conserved while D2 is the least conserved
between MtTOP1 and EcTOP1.
Similarly, when the N-terminal region of MtTOP1 is superimposed on EcTOP3 (Fig. 7B),
the calculated rmsd value was 3.66 Å with a sequence identity of 21.5%. Relative domaindomain movement of these enzymes in their crystals could impact the superposition
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involving multiple domains. Pair-wise individual domain alignments of MtTOP1 and
EcTOP3 yielded rmsd values of 1.76 Å, 1.93 Å, 2.11 Å, and 1.85 Å for D1, D2, D3 and D4,
respectively. Their sequence identities are 28.3%, 19.5%, 31.3%, and 25.2%, respectively.
From these comparisons it is clear that MtTOP1 is closer to EcTOP1 than EcTOP3.
However, MtTOP1 has some local structural features similar to EcTOP3, to be elaborated on
later. There is no metal binding observed at the active site of the Apo form of MtTOP1.
Unique features of individual N-terminal domains of MtTOP1

Author Manuscript

The D1 or so called TOPRIM (TOpoisomerase-PRIMse) domain is the most conserved
domain in the N-terminal region among these enzymes based on the alignments above. In
MtTOP1 it includes residues G17 to D157 except the region from R50 to S86, which sticks
out from D1 toward D4 (colored grey in Fig. 5). In the EcTOP1 structure, a similar
protruding region is defined as a part of D4 because of its close association with the main
body of D4 and its partial role in forming a ssDNA-binding groove on D4.20, 21 For
comparison, we define this region in MtTOP1 as a part of D4 as well, although it is
described as a part of D1 in the EcTOP3 structure.22 In MtTOP1, this protruding region has
no sequence homology to the corresponding region in EcTOP1 and is 15 amino acids shorter
(Figs. 5 and 6). Though this protruding region from R50 to S86 does not have a prominent
α-helix seen in EcTOP1 (Fig. 7A), it is well structured, comprising five β turns and a short β
hairpin. Interestingly, in EcTOP3, this portion is also a tight loop, similarly consisting of
multiple β turns22 (Fig. 7B). The significance of the structural variation of the protrusion
remains unknown.

Author Manuscript
Author Manuscript

The hinge domain D2 comprises two sequentially separated regions: F213 to R302 (β1-β2α1-β3) and D434 to R516 (β4-β5-α2-β6) (Figs. 5 and 6). Though the sequence identities of
the domain between MtTOP1 and EcTOP1 or EcTOP3 are as low as 26.9% and 19.5%,
respectively, the hinge domain of MtTOP1 essentially has a similar structure to that of the
two E. coli topoisomerases except for two rather prominent insertions in MtTOP1. The first
insertion (T252 to I270, colored magenta in Figs. 5A and 7) creates a large loop between β2
and α1 on the right side behind the toroid hole. The magenta loop is rich in charged residues
and seemingly creates a positively charged edge on the top of the toroid hole (Fig. 5). A
smaller insertion (loop214-255) was found in EcTOP3, which forms a helical motif instead
(Fig 7B).22 The second insertion (G480 to A485, colored red in Figs. 5A and 7) is part of a
long loop between α2 and β6 in the bottom front of the toroid hole. This loop is negatively
charged. The two charged loops (colored in magenta and red) positioned on the two sides of
the toroid hole of MtTOP1 might play an important coordinating role in the proposed route
of the passing strand during catalysis of DNA relaxation by attracting or repelling DNA. The
magenta colored insertion T252 to I270 is unique to MtTOP1 and EcTOP3 and may play
roles that differentiate MtTOP1 and EcTOP3 from EcTOP1.
D3 is an all α-helical domain (P303 to A433), including the catalytic residue Y342 on a loop
between the α2 and α3 helices. The catalytic site of the Apo form of MtTOP1 centered at
Y342 shows no significant conformational variation compared to the catalytic sites of the
Apo forms of either EcTOP123 or EcTOP3,22 indicating the same catalytic mechanism for
these type IA topoisomerases. The catalytic site also includes the DxDREG TOPRIM
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sequence motif from D1, which is quite conserved (Fig. 6). The only difference is the
variation in residue x, which is Gly112 in MtTOP1, a Leu in EcTOP1, and a Pro in EcTOP3.
Additionally, between the α3 and α4 helices of D3, there is a long loop of 35 residues,
including the sequence motif Q386EAHEAIRP that is highly conserved in type IA
topoisomerases, with the invariant histidine proposed to play a role in catalysis24. In all of
the EcTOP1 structures determined to date, a part of the loop upstream of the conserved
sequence is partially disordered. In MtTOP1, in contrast, this loop is well structured without
any break and seemingly correlates to the formation of the α4 helix (highlighted in blue, Fig.
5), which degenerates to a β-turn in EcTOP1 (Fig. 7A).

Author Manuscript

In MtTOP1, a feature of D4 may be related to one of its physiological functions; the last
helix in D4 (α8) has an insertion of 14 residues (G610 to G623, colored purple in Figs. 5
and 7) in the middle of the helix, which is not found in EcTOP1 and EcTOP3. The purple
insertion is right below the decatenation loop of EcTOP3,22 which is also from D4 (Fig. 7B).
The actual functionality of this unusual insertion in the α8 helix needs to be explored. The
α8 helix is then followed by a linker to the C-terminal domains. The linker is very different
in sequence and structure among MtTOP1, EcTOP1, and EcTOP3, indicating the connection
between the N- and C-terminal domains varies significantly among these topoisomerases.
However, the DNA-binding groove is mostly conserved (Fig. 5). Two negatively charged
sulfate groups likely from the crystallization buffer were identified inside the positively
charged DNA-binding groove (not shown). They may mimic two phosphate groups of DNA
in their interactions within the groove.
Novel MtTOP1 C-terminal domain
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D5 is the first C-terminal domain, from R638 to P705. This small domain of 67 residues is
composed of a four-stranded antiparallel β-sheet with a C-terminal helix packed against the
β-sheet on one side (Fig. 8). Hydrophobic interaction dominates the interaction between the
β-sheet and the helix. An additional salt bridge (R668-E699) and hydrogen bonds are also
observed. The helix apparently plays an important role in stabilizing the β-sheet and the
small domain. The other side of the β-sheet is open and hosts several residues that may be
involved in DNA binding. The conserved tyrosine Y665, the third residue of the β3-strand,
could be a key residue in the interaction of D5 with DNA by forming π–stacking(s) with the
base(s) of DNA (Fig. 5). The other residues Y656 and R658 on the β2-strand, R681 on the
β4-strand and K661 on the sharp β2-β3 turn (Fig. 5) can potentially form π–stacking, π–
cation, or other forms of interaction with DNA.
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A Dali structural homology search25 of MtTOP1 results in no significant hits (Z score ≤ 4.3,
rmsd ≥ 2.6, and sequence identity ≤ 14%) even though a protein fold containing a helix
packed against one face of an anti-parallel β-sheet is common. This indicates the structural
novelty of the MtTOP1 C-terminal domain.
Classification of topoisomerase C-terminal domains
From Fig. 1, it is clear that the four MtTOP1 C-terminal domains exemplified by D5
represent one subgroup (Topo_C_Rpt) of bacterial topoisomerase C-terminal repeats. In this
subgroup a C-terminal domain has a four-stranded antiparallel β-sheet compounded or
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stabilized by a crossing-over α-helix on one side of the β-sheet. Besides MtTOP1,
Topo_C_Rpt can also be found in other Mycobacterium species as well as related species of
Actinobacteria (Supplementary Fig. 1). The second subgroup of the C-terminal domain of
topoisomerases, namely Topo_C_ZnRpt, is represented by the 4-Cys zinc ribbon domains of
EcTOP1, in which one four-stranded antiparallel β-sheet is stabilized by a Zn-binding site on
the top of each domain9 (PDB ID: 4RUL). Variations of these two subgroups or even new
subgroups are expected with further structural characterization of topoisomerases. For
example, the only C-terminal domain of Thermotoga maritima topoisomerase I can be
regarded as a member of Topo_C_ZnRpt but without Zn binding.

Discussion
Author Manuscript
Author Manuscript

Trapping of the bacterial topoisomerase I covalent complex on cleaved chromosomal DNA
has been shown to result in rapid bacterial cell death, validating this class of enzyme as a
useful target for novel bactericidal antibiotics26, 27. The structure of MtTOP1-704t reported
here provides details of the active site and its vicinity that would be useful for the discovery
of poison-type inhibitors for trapping of the topoisomerase covalent intermediate.
Topoisomerase poisons are typically interfacial inhibitors interacting with both DNA and the
topoisomerase.28 Interactions between potential poison-type inhibitors and MtTOP1 protein
residues near the active site are needed to confer high binding affinity and selectivity. For
example, while m-AMSA has been shown to inhibit M. tuberculosis topoisomerase I and
growth of M. tuberculosis,29 this compound has much greater selectivity for eukaryotic type
II topoisomerases. A binding pocket for functional groups in m-AMSA present near the
active site of human type II topoisomerases accounts for the specific interactions with mAMSA and its effectiveness as an anticancer drug. The construct of MtTOP1-704t could be
utilized in the future for co-crystallization of an enzyme-DNA-inhibitor ternary complex to
further enable the discovery of new TB therapies.

Author Manuscript

Catalytic inhibitors of MtTOP1 could also be useful for treating TB by inhibiting the
essential function of the enzyme. MtTOP1-704t has no detectable relaxation activity. Some
or all other C-terminal parts of MtTOP1 including D6, D7, and D8 or even the flexible tail
may be required for relaxation of DNA supercoiling. MtTOP1-704t can carry out DNA
cleavage-religation and catalyze the catenation of ssDNA with efficiencies comparable to
those of full-length MtTOP1. All Mycobacterium species and most members of the
Actinobacteria phylum have only one type IA topoisomerase encoded in their genomes.
These include the topoisomerase I with a domain organization similar to MtTOP1 found in
the pathogens Corynebacterium diphtheria and Actinomyces odontolyticus (Supplementary
Fig. 1) that are likely to also be essential for viability. Unique features observed in the Nterminal domains of MtTOP1, such as the charged loops on opposite sides of the toroid hole
and the insertion at the position near where the decatenation loop of EcTOP3 can be found,
may also have evolved for MtTOP1 to carry out all the catalytic functions that may be
associated with bacterial type IA topoisomerases. Further studies are required to determine
the biochemical and physiological significance of these unique structural features.
The novel structure of the MtTOP1 C-terminal domain D5 reported here provides new
insights into the folding of diverse bacterial topoisomerase I proteins, particularly their C-
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terminal regions. The organization of repeated bacterial topoisomerase I C-terminal domains
may have arisen during evolution through gene duplication. Gene segments that encode a
specific protein fold that can interact with ssDNA have been combined in the evolutionary
process with the segments encoding the N-terminal domains that have the DNA cleavagereligation active site at the entrance of a toroid hole. Different repeats of the Topo_C_Rpt or
Topo_C_ZnRpt domains or their likenesses are utilized in each bacterial species for the
DNA-protein or protein-protein interactions that are required for the catalytic activity and
physiological functions of this ubiquitous enzyme. Interaction between the C-terminal
domains of EcTOP1 and RNA polymerase is important for the efficient removal of
transcription-driven negative supercoiling during transcription elongation.30 The C-terminal
domains of MtTOP1 may interact similarly with M. tuberculosis RNA polymerase for
relieving the torsional stress generated during transcription.

Author Manuscript

The flexibility of the linkers between the individual C-terminal domains may account for the
difficulty encountered in the crystallization of full-length bacterial topoisomerase I proteins.
This could be addressed by introducing a DNA binding substrate or protein interaction
partner to limit the degree of interdomain movement, facilitating the crystallization of full
length proteins. Successful determination of full-length Mycobacterium topoisomerase I
crystal structures will provide additional new insights into the mechanism and function of
this essential enzyme.

Materials and Methods
Cloning, expression, and purification

Author Manuscript
Author Manuscript

A clone for expression of MtTOP1-704t was constructed using the Gibson Assembly Master
Mix from New England BioLabs, placing the coding sequence of residues 2-704 of MtTOP1
under the control of the T7 promoter in pET-His6-Mocr TEV-LIC cloning vector (2O-T)
that was a gift from Scott Gradia (Addgene plasmid # 29710). The MtTOP1-704t protein
was expressed in the E. coli T7 Express Crystal strain (New England BioLabs). Cells were
grown in Luria Bertani broth at 37°C to the exponential phase (OD600 = 0.4) and left at
room temperature for 20 min. Recombinant protein expression was induced by adding 1 mM
IPTG. After overnight induction at 22°C, the cells were collected and subjected to freezethaw lysis in buffer (20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 20 mM imidazole, 1
mg/ml lysozyme). The recombinant protein in the soluble lysate was allowed to bind to Ni
Sepharose 6 Fast Flow (GE Healthcare) and packed into a column. After extensive washing
with buffer (20 mM sodium phosphate pH 7.4, 0.5 M NaCl, 20 mM imidazole), the
topoisomerase protein was eluted with buffer (20 mM sodium phosphate, pH 7.4, 0.5 M
NaCl, 500 mM imidazole). Following treatment with TEV protease, the protein was passed
through the Ni Sepharose again to remove the His6-Mocr tag. Additional purification was
achieved with single-stranded DNA cellulose column chromatography (Sigma) using an
increasing concentration gradient of KCl to elute the protein. The final purification step
utilized an S300 size exclusion chromatography column as described previously.31 The
purified protein was concentrated to about 85 mg/ml for crystallization.
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The screening for crystallization conditions was set up with a Mosquito nanoliter liquid
handler (TTP LabTech) using the sitting drop vapor diffusion technique in 96-well
CrystalQuick plates (Greiner). For each condition, 0.2 μl of protein and 0.2 μl of
crystallization formulation were mixed, and the mixture was equilibrated against 140 μl of
the crystallization solution in each reservoir well. The crystallization screens used were
MCSG-1–4 at 16°C. Diffraction quality crystals appeared under the following condition: 0.2
M Ammonium Sulfate, 0.1 M Tris:HCl pH 8.5, and 25% (w/v) PEG3350. Prior to data
collection, the crystals were treated with cryoprotectant (20% glycerol in crystallization
buffer) and cryocooled directly in liquid nitrogen.
X-ray diffraction and structure determination
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Sets of single-wavelength diffraction data were collected at 12.66 keV at 100 K from
cryocooled MtTOP1-704t crystals. All data were obtained at the 19-ID beamline of the
Structural Biology Center at the Advanced Photon Source at Argonne National Laboratory
using the program SBCcollect.32 The intensities of each data set were integrated, scaled, and
merged with the HKL3000 program suite33 (Table 1). The best data set measured has a
resolution limit of 2.52 Å. The structures of the MtTOP1-704t crystal were determined using
the molecular replacement method.17 The best search template used was the structures of the
N-terminal domains (D1-D4) of full-length EcTOP1 (PDB ID: 4RUL). Subsequent model
rebuilding for the N-terminal domains and building the first C-terminal domain (D5) based
on difference maps was performed using the program COOT34. After several alternative
cycles of model building and refinement, the final model was refined using the program
Phenix.refine35 (Table 1). Structural validation was performed using the program
MolProbity.36
Relaxation activity assay
The relaxation reaction was carried out in 20 μl of 10 mM Tris-HCl (pH 8.0) 50 mM NaCl,
0.1 mg/mL gelatin, and 5 mM MgCl2 with 250 ng of supercoiled pBAD/Thio plasmid DNA
purified by CsCl gradient centrifugation. Following incubation at 37°C for 30 min, the
reactions were terminated and analyzed by agarose gel electrophoresis as previously
described.37
Assay of oligonucleotide DNA cleavage and religation
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The 32 base oligonucleotide substrate 5′CAGTGAGCGAGCTTCCGCT↓TGACATCCCAATA-3′ with a preferred cleavage site for
MtTOP1 indicated by the arrow has been previously described.13 It was labeled at the 5′-end
with γ-32P-ATP and T4 polynucleotide Kinase. Cleavage activity was assayed by incubating
the labeled oligonucleotide (0.5 pmole) with MtTOP1 and MtTOP1-704t in 5 μl of 10 mM
Tris-HCl pH 8.0 at 37°C for 30 min. Intramolecular religation was initiated by addition of
MgCl2 followed by further incubation for 15 min. The reactions were terminated by the
addition of an equal volume of sequencing gel loading buffer. The reaction substrate and the
19 base-long cleavage product were separated by electrophoresis in a 15% sequencing gel
followed by Phosphor-Imager analysis of the gel.
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Catenation activity assay
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Catenation of M13 ssDNA circles was assayed with a protocol similar to previously
described conditions16. The reaction volume of 20 μl contained 20 mM Tris-HCl (pH 8.0),
20 mM KCl, 2 mM MgCl2, 0.05 mg/ml BSA, 10 mM spermidine, 30% glycerol, and 0.5 μg
of M13 ssDNA (from Bayou Biolabs). After incubation with the indicated amount of
topoisomerase protein for 1 h at 52°C, the reactions were terminated with the addition of 1%
SDS, 5 mM EDTA, and 12 μg of proteinase K, and left at 37°C for 1 h before
electrophoresis in 0.8% agarose gel.
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Author Manuscript

Acknowledgments
The authors wish to thank members of the Structural Biology Center at Argonne National Laboratory for their help
with data collection at the 19-ID beamline. We are grateful to Ms. Gekleng Chhor for her proofreading. This work
was supported by the National Institute of Health grants GM054226 and AI069313 to YT and GM094585 to AJ.
The use of SBC 19-ID was supported by the U. S. Department of Energy, Office of Biological and Environmental
Research, under contract DE-AC02-06CH11357.

Abbreviations
MtTOP1

M. tuberculosis topoisomerase I

TB

tuberculosis

Author Manuscript

References

Author Manuscript

1. Vos SM, Tretter EM, Schmidt BH, Berger JM. All tangled up: how cells direct, manage and exploit
topoisomerase function. Nat Rev Mol Cell Biol. 2011; 12:827–841.10.1038/nrm3228 [PubMed:
22108601]
2. Chen SH, Chan NL, Hsieh TS. New mechanistic and functional insights into DNA topoisomerases.
Annu Rev Biochem. 2013; 82:139–170.10.1146/annurev-biochem-061809-100002 [PubMed:
23495937]
3. Forterre P, Gadelle D. Phylogenomics of DNA topoisomerases: their origin and putative roles in the
emergence of modern organisms. Nucleic Acids Res. 2009; 37:679–692.10.1093/nar/gkp032
[PubMed: 19208647]
4. Dawson R, Diacon AH, Everitt D, van Niekerk C, Donald PR, Burger DA, Schall R, Spigelman M,
Conradie A, Eisenach K, Venter A, Ive P, Page-Shipp L, Variava E, Reither K, Ntinginya NE, Pym
A, von Groote-Bidlingmaier F, Mendel CM. Efficiency and safety of the combination of
moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis
treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drugresistant pulmonary tuberculosis. Lancet. 2015; 385:1738–1747. pii. [PubMed: 25795076]
5. Ahmed W, Menon S, Godbole AA, Karthik PV, Nagaraja V. Conditional silencing of topoisomerase
I gene of Mycobacterium tuberculosis validates its essentiality for cell survival. FEMS Microbiol
Lett. 2014; 353:116–123. [PubMed: 24593153]
6. Sridevi JP, Suryadevara P, Janupally R, Sridhar J, Soni V, Anantaraju HS, Yogeeswari P, Sriram D.
Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: a study against
active, dormant and resistant tuberculosis. Eur J Pharm Sci. 2015; 72:81–92.10.1016/j.ejps.
2015.02.017 [PubMed: 25769524]

J Mol Biol. Author manuscript; available in PMC 2017 January 16.

Tan et al.

Page 11

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

7. Godbole AA, Ahmed W, Bhat RS, Bradley EK, Ekins S, Nagaraja V. Targeting Mycobacterium
tuberculosis topoisomerase I by small-molecule inhibitors. Antimicrob Agents Chemother. 2015;
59:1549–1557.10.1128/AAC.04516-14 [PubMed: 25534741]
8. Ravishankar S, Ambady A, Awasthy D, Mudugal NV, Menasinakai S, Jatheendranath S, Guptha S,
Sharma S, Balakrishnan G, Nandishaiah R, Ramachandran V, Eyermann CJ, Reck F, Rudrapatna S,
Sambandamurthy VK, Sharma UK. Genetic and chemical validation identifies Mycobacterium
tuberculosis topoisomerase I as an attractive anti-tubercular target. Tuberculosis (Edinb). 2015
S1472-9792(15)20742-1 [pii].
9. Tan K, Zhou Q, Cheng B, Zhang ZA, Joachimiak A, tse-Dinh YC. Structural basis for suppression
of hypernegative DNA supercoiling by E. coli topoisomerase I. Nucleic Acids Res. 2015 Oct 20.
pii: gkv1073. Epub ahead of print.
10. Schuster-Bockler B, Schultz J, Rahmann S. HMM Logos for visualization of protein families.
BMC Bioinformatics. 2004; 5:7. [PubMed: 14736340]
11. Drozdetskiy A, Cole C, Procter J, Barton GJ. JPred4: a protein secondary structure prediction
server. Nucleic Acids Res. 2015; 43:W389–94. [PubMed: 25883141]
12. Hansen G, Harrenga A, Wieland B, Schomburg D, Reinemer P. Crystal structure of full length
topoisomerase I from Thermotoga maritima. J Mol Biol. 2006; 358:1328–1340. [PubMed:
16600296]
13. Ahmed W, Bhat AG, Leelaram MN, Menon S, Nagaraja V. Carboxyl terminal domain basic amino
acids of mycobacterial topoisomerase I bind DNA to promote strand passage. Nucleic Acids Res.
2013; 41:7462–7471.10.1093/nar/gkt506 [PubMed: 23771144]
14. Annamalai T, Dani N, Cheng B, Tse-Dinh YC. Analysis of DNA relaxation and cleavage activities
of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and
purification protocol. BMC Biochem. 2009; 10:18.10.1186/1471-2091-10-18 [PubMed:
19519900]
15. Terekhova K, Marko JF, Mondragon A. Studies of bacterial topoisomerases I and III at the singlemolecule level. Biochem Soc Trans. 2013; 41:571–575. [PubMed: 23514156]
16. Bhaduri T, Bagui TK, Sikder D, Nagaraja V. DNA topoisomerase I from Mycobacterium
smegmatis An enzyme with distinct features. J Biol Chem. 1998; 273:13925–13932. [PubMed:
9593741]
17. Vagin A, Teplyakov A. Molecular replacement with MOLREP. Acta Crystallogr D Biol
Crystallogr. 2010; 66:22–25. [PubMed: 20057045]
18. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol.
2007; 372:774–797. [PubMed: 17681537]
19. Krissinel E, Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure
alignment in three dimensions. Acta Crystallogr D Biol Crystallogr. 2004; 60:2256–2268.
[PubMed: 15572779]
20. Perry K, Mondragon A. Structure of a complex between E. coli DNA topoisomerase I and singlestranded DNA. Structure. 2003; 11:1349–1358. [PubMed: 14604525]
21. Cheng B, Feng J, Mulay V, Gadgil S, Tse-Dinh YC. Site-directed mutagenesis of residues
involved in G Strand DNA binding by Escherichia coli DNA topoisomerase I. J. Biol. Chem.
2004; 279:39207–39213.10.1074/jbc.M405891200
22. Mondragon A, DiGate R. The structure of Escherichia coli DNA topoisomerase III. Structure.
1999; 7:1373–1383. [PubMed: 10574789]
23. Lima CD, Wang JC, Mondragon A. Three-dimensional structure of the 67K N-terminal fragment
of E. coli DNA topoisomerase I. Nature. 1994; 367:138–146. [PubMed: 8114910]
24. Perry K, Mondragon A. Biochemical characterization of an invariant histidine involved in
Escherichia coli DNA topoisomerase I catalysis. J Biol Chem. 2002; 277:13237–13245.10.1074/
jbc.M112019200 [PubMed: 11809772]
25. Holm L, Rosenstrom P. Dali server: conservation mapping in 3D. Nucleic Acids Res. 2010;
38:W545–9.10.1093/nar/gkq366 [PubMed: 20457744]
26. Tse-Dinh YC. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.
Future Med Chem. 2015; 7:459–471. [PubMed: 25875873]

J Mol Biol. Author manuscript; available in PMC 2017 January 16.

Tan et al.

Page 12

Author Manuscript
Author Manuscript
Author Manuscript

27. Tse-Dinh YC. Bacterial topoisomerase I as a target for discovery of antibacterial compounds.
Nucleic Acids Res. 2009; 37:731–737.10.1093/nar/gkn936 [PubMed: 19042977]
28. Pommier Y. Drugging topoisomerases: lessons and challenges. ACS Chem Biol. 2013; 8:82–
95.10.1021/cb300648v [PubMed: 23259582]
29. Godbole AA, Ahmed W, Bhat RS, Bradley EK, Ekins S, Nagaraja V. Inhibition of Mycobacterium
tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison. Biochem
Biophys Res Commun. 2014; 446:916–920.10.1016/j.bbrc.2014.03.029 [PubMed: 24642256]
30. Cheng B, Zhu CX, Ji C, Ahumada A, Tse-Dinh YC. Direct interaction between Escherichia coli
RNA polymerase and the zinc ribbon domains of DNA topoisomerase I. J. Biol. Chem. 2003;
278:30705–30710. pii.
31. Zhang Z, Cheng B, Tse-Dinh YC. Crystal structure of a covalent intermediate in DNA cleavage
and rejoining by Escherichia coli DNA topoisomerase I. Proc. Natl Acad Sci U S A. 2011;
108:6939–6944.10.1073/pnas.1100300108
32. Rosenbaum G, Alkire RW, Evans G, Rotella FJ, Lazarski K, Zhang RG, Ginell SL, Duke N,
Naday I, Lazarz J, Molitsky MJ, Keefe L, Gonczy J, Rock L, Sanishvili R, Walsh MA, Westbrook
E, Joachimiak A. The Structural Biology Center 19ID undulator beamline: facility specifications
and protein crystallographic results. J Synchrotron Radiat. 2006; 13:30–45. pii. [PubMed:
16371706]
33. Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. HKL-3000: the integration of data
reduction and structure solution--from diffraction images to an initial model in minutes. Acta
Crystallogr D Biol Crystallogr. 2006; 62:859–866.10.1107/S0907444906019949 [PubMed:
16855301]
34. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr
D Biol Crystallogr. 2010; 66:486–501.10.1107/S0907444910007493 [PubMed: 20383002]
35. Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M,
Terwilliger TC, Urzhumtsev A, Zwart PH, Adams PD. Towards automated crystallographic
structure refinement with phenix. refine. Acta Crystallogr D Biol Crystallogr. 2012; 68:352–367.
[PubMed: 22505256]
36. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB
3rd, Snoeyink J, Richardson JS, Richardson DC. MolProbity: all-atom contacts and structure
validation for proteins and nucleic acids. Nucleic Acids Res. 2007; 35:W375–83. pii. [PubMed:
17452350]
37. Zhu CX, Tse-Dinh YC. The acidic triad conserved in type IA DNA topoisomerases is required for
binding of Mg(II) and subsequent conformational change. J Biol Chem. 2000; 275:5318–5322.
[PubMed: 10681504]

Author Manuscript
J Mol Biol. Author manuscript; available in PMC 2017 January 16.

Tan et al.

Page 13

Author Manuscript

Highlights
•

A long-awaited crystal structure of M. tuberculosis Topoisomerase I (MtTOP1)

•

Recognition of individual MtTOP1 C-terminal domains and their organization

•

Rational design of truncated MtTOP1 enables production of diffraction quality
crystals

•

Charged loops in the toroid hole are unique features of MtTOP1 N-terminal
domains

•

Novel protein fold of MtTOP1 C-terminal domains defines a subset of
topoisomerases
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Fig. 1. Division of the C-terminal region of M. tuberculosis topoisomerase I into four domains
and a flexible tail

Author Manuscript

The conserved residues among the four domains are highlighted in red, including the
GxxGPY sequence motif. Besides the conserved tyrosine residues within the GxxGPY
motifs, other possible DNA binding residues are highlighted in magenta (for possible π
stacking to the bases of nucleotides) or blue (for possible π–cation or salt bridge or hydrogen
bond to DNA). The secondary structures of D5 are indicated above the appropriate sequence
of D5. The highly positively charged tail after D8 is listed below the alignment, and it is
presumably structurally flexible.
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Fig. 2. Assay of relaxation activity of full length MtTOP1 and MtTOP1-704t

Supercoiled pBAD/Thio plasmid DNA was incubated with the indicated amount of MtTOP1
or MtTOP1-704t at 37°C for 30 min before separation of the supercoiled DNA from relaxed
topoisomers by agarose gel electrophoresis.
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Fig. 3. DNA cleavage and religation by MtTOP1-704t
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(A) Comparison of the formation of DNA cleavage product by MtTOP1 and MtTOP1-704t.
O: Oligonucleotide substrate; P: Major cleavage product. (B) Intramolecular DNA religation
by MtTOP1 and MtTOP1-704t. Lane 1: Oligonucleotide substrate with no enzyme; Lanes 2
and 5: DNA cleavage reaction. (C) DNA religation (R) with no Mg2+ present; Lanes 3 and
6: DNA religation (R) with 5 mM MgCl2 and 1 M NaCl added; Lanes 4 and 7: DNA
religation (R) with 10 mM MgCl2 and 1 M NaCl added.
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Fig. 4. Catenation of single-stranded M13mp18 DNA by MtTOP1 and MtTOP1-704t
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Single-stranded M13mp18 DNA was incubated with the indicated amount of MtTOP1 or
MtTOP1-704t before proteinase K treatment. C: circular ssDNA; L: linear ssDNA; CC:
catenated circular ssDNA.
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Fig. 5. Structure of MtTOP1-704t
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(A) A ribbon diagram of the structure of MtTOP1-704t. The main bodies of the N-terminal
D1, D2, D3, and D4 domains and the C-terminal D5 domain are colored in salmon, yellow,
cyan, green, and pink, respectively. Numbering of the secondary structures are based on
each individual domain. The protrusion from D1 that is regarded as a part of D4, as
described in the EcTOP1 structure, is colored in grey. In D2, the two loops that include
unique insertions are colored in magenta (the loop between β2 and α1) and red (the loop
between α2 and β3). In D3, the α4 helix that degenerated to a β-turn in the EcTOP1
structures is highlighted in blue. The catalytic residue Y342 is drawn in stick format. In D4,
the unusual insertion in the middle of the α8 helix is highlighted in purple. (B) and (C) The
molecular surface representations of MtTOP1-704t. The orientation of the molecule in (B) is
the same as that in (A). The orientation of the molecule in (C) has a 180° rotation around the
vertical axis with respect to the view in (B). (D) and (E) The electrostatic potential surface
representations of MtTOP1-704t. The surface of MtTOP1-704t is colored according to
amino acid residue charge, ranging from blue (positive) to red (negative). The orientation of
the molecule in (D) is similar to that in (B), but with a −15° rotation around the horizontal
axis with respect to the view in (B) for a better view of the DNA binding groove. The
orientation of the molecule in (E) is the same as that in (C). Figures 5, 7, and 8 are prepared
with the program PyMOL (http://www.PyMOL.org).
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Fig. 6. N-terminal domain arrangement of MtTOP1 and multiple sequence alignment
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(A) The N-terminal domain arrangement of MtTOP1. Domains D1, D2, D3, and D4 are
colored in salmon, yellow, cyan, and green, respectively. The protruded region from D1 in
MtTOP1 and EcTOP1, is regarded as a part of D4. In EcTOP3, it is described as a part of
D1.22 The asterisk indicates the location of the catalytic tyrosine residue. (B) Structurebased Multiple Sequence Alignment with EcTOP1 and EcTOP3. The residues that are
identical between MtTOP1 and EcTOP1 are colored in red. The residues of EcTOP3 that are
conserved in both MtTOP1 and EcTOP1 are also colored in red. The residues in regions of
similar secondary structures but different conformations between MtTOP1 and EcTOP1 are
colored in green. The residues in regions with neither sequential nor structural alignments
are colored in blue. The disordered residues in the structures of EcTOP1 are shown in lower
case. The secondary structures of MtTOP1, α-helices as coils and β-strands as arrows, are
drawn above the appropriate sequence of MtTOP1. The numbering of these secondary
structures is based on each domain for descriptive convenience. The same color schemes for
domains used in (A) are used for highlighting their corresponding sequences of MtTOP1 and
EcTOP1 in the structural alignment.
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Fig. 7. N-terminal region structural alignments of MtTOP1 with EcTOP1 and EcTOP3
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(A) Ribbon diagrams of the superposition of MtTOP1 with EcTOP1 in a front view and in a
side view. The color scheme for the MtTOP1 domains and featured structural parts is the
same as in Fig. 5. EcTOP1 is colored in grey. (B) Ribbon diagrams of the superposition of
MtTOP1 with EcTOP3 in a front view and in a side view. EcTOP3 is colored in grey, and its
decatenation loop is labeled.
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Fig. 8. Structure of the first MtTOP1 C-terminal domain (D5)

(A) A ribbon diagram of D5. The residues (G660, G663, and Y665) that are part of the
highly conserved sequence motif GxxGPY in each MtTOP1 C-terminal domain are
highlighted in magenta. Several residues (including Y665) that are potentially involved in
DNA binding are drawn in stick format. (B) A stereo view of the β-sheet of D5 and several
exposed residues on the β-sheet mentioned in (A). The electron density drawn in grey mesh
is calculated from a weighted 2Fo-Fc map and contoured at the 1σ level.
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Data collection and refinement statistics
Data collection

MtTOP1

Space group

P212121

Unit Cell dimensions
a, b, c (Å)

64.00,93.15, 140.2

α, β, γ (°)

90, 90, 90

Author Manuscript

MW Da (residue)

77,468.3 (703) 1

Mol (AU)

1

Wavelength (Å)

0.9792

Resolution (Å)

42.0-2.52

Number of Unique reflections

28,858

Completeness (%)

99.2 (97.6)2

Redundancy

5.6 (5.6)2

Rmerge

0.098 (0.696)2

I/σ (I)

14.0 (2.0)2

Solvent content (%)

54.3

Phasing
Resolution (Å)

42.0-3.00

Correlation coefficient 3

0.416

Refinement

Author Manuscript

Resolution

42.0-2.52

No. reflections (work/test)

26,111/1,380

Rwork/Rfree

0.174/0.241

No. of atoms
Protein

5334

Water/Others

72/47

B-factors (Å2)
Protein

55.0

Water/Others

40.7/77.47

R.m.s deviation
Bond length (Å)

0.008

Bond angle (°)

1.083

PDB code

5D5H

Author Manuscript

1

Not including three N-terminal vector-derived residues, SNA;

2

Last resolution bin, 2.52-2.56 Å;

3

Molecular replacement
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